<DrugInformationSummary id="CDR0000744060"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about ponatinib hydrochloride
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/ponatinibhydrochloride">Ponatinib Hydrochloride</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000595060">ponatinib hydrochloride</TerminologyLink><GlossaryLink ref="CDR0000744185">ponatinib hydrochloride</GlossaryLink><USBrandNames><USBrandName>Iclusig</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>poh-NA-tih-nib HY-droh-KLOR-ide</TermPronunciation><MediaLink ref="CDR0000746318" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000746319" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=PONATINIB+HYDROCHLORIDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Ponatinib Hydrochloride</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=PONATINIB+HYDROCHLORIDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Ponatinib hydrochloride
         is approved 
         for use in adults to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000045586" dictionary="Cancer.gov" audience="Patient">Acute lymphoblastic leukemia</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000044179" dictionary="Cancer.gov" audience="Patient">Philadelphia chromosome</GlossaryTermRef> <GlossaryTermRef href="CDR0000044710" dictionary="Cancer.gov" audience="Patient">positive</GlossaryTermRef>. It is used:<ItemizedList Style="bullet" id="_12"><ListItem>With chemotherapy in patients whose cancer is newly diagnosed.¹</ListItem><ListItem>Alone in patients whose cancer has a <GlossaryTermRef href="CDR0000806984" dictionary="Cancer.gov" audience="Patient">T315I mutation</GlossaryTermRef> or cannot be treated with other <GlossaryTermRef href="CDR0000750798" dictionary="Cancer.gov" audience="Patient">kinase inhibitors</GlossaryTermRef>.</ListItem></ItemizedList> </ListItem>
   <ListItem><Strong><GlossaryTermRef href="CDR0000044901" dictionary="Cancer.gov" audience="Patient">Chronic myelogenous leukemia</GlossaryTermRef></Strong> (CML). It is used:<ItemizedList Style="bullet" id="_13"><ListItem>In patients with <GlossaryTermRef href="CDR0000045160" dictionary="Cancer.gov" audience="Patient">chronic phase CML</GlossaryTermRef> whose cancer did not respond to at least two kinase inhibitors or who cannot be treated with other kinase inhibitors.</ListItem><ListItem>In patients with <GlossaryTermRef href="CDR0000046212" dictionary="Cancer.gov" audience="Patient">accelerated phase</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046113" dictionary="Cancer.gov" audience="Patient">blastic phase CML</GlossaryTermRef> whose cancer cannot be treated with other kinase inhibitors.</ListItem><ListItem>In patients whose cancer has a T315I mutation.<Para id="_14">Ponatinib hydrochloride is not approved to treat newly diagnosed chronic phase CML.</Para></ListItem></ItemizedList></ListItem>
   </ItemizedList>
  <Para id="_11">¹This use is approved under FDA’s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that ponatinib hydrochloride provides a clinical benefit in these patients.</Para><Para id="_6">Ponatinib hydrochloride  is being studied in the treatment of other types of cancer.</Para></Section><Section id="_About"><Title>More About Ponatinib Hydrochloride</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/595060">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.19">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a613029.html">Ponatinib Hydrochloride</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.20"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.21">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C78194">Find Clinical Trials for Ponatinib Hydrochloride</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2012-12-26</DateFirstPublished><DateLastModified>2024-04-09</DateLastModified></DrugInformationSummary>
